Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduction of Ischemic Myocardium with Ranolazine Treatment in Acute Myocardial Ischemia (RIMINI Pilot Trial)
2013-000030-35Phase 2Completed
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of ranolazine in coronary arteriosclerosis, cardiac ischemia and myocardial infarction (MI), sponsored by University Medical Center Hamburg-Eppendorf. Primary endpoints: Area of ischemic myocardium and Cardiac biomarkers after treatment. Started Feb 2013; status: completed.
02
Drugs
ranolazine
03
Conditions
coronary arteriosclerosiscardiac ischemiamyocardial infarction (MI)
Beyond the preview
Go deeper on 2013-000030-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000030-35.